Guardant Health, Inc. (GH) vs Labcorp Holdings Inc. (LH)
- Guardant Health, Inc. GH 154.16 −8.55%
- Labcorp Holdings Inc. LH 362.28 −1.50%
Guardant Health, Inc. and Labcorp Holdings Inc. are both Diagnostics & Research companies. Labcorp Holdings Inc. is the larger, with a market value of $29.5B against $20.6B — 1.4× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Labcorp Holdings Inc. trades at 29.5×. Guardant Health, Inc. grew revenue faster over the last twelve months: 41.7% against 6.02%. Labcorp Holdings Inc. has the higher net margin (6.88% vs −37.9%) and the higher return on invested capital (6.76% vs −25.7%). Across the 18 metrics below, Labcorp Holdings Inc. leads on 10 and Guardant Health, Inc. on 8.
Valuation
Profitability
| Metric | GH | LH | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.19% | 28.96% | 48.32% |
| Operating margin | (39.41%) | 10.29% | (5.68%) |
| Net margin | (37.93%) | 6.88% | (4.10%) |
| Free cash flow margin | (18.15%) | 8.87% | 0.00% |
| Return on equity | 153.90% | 11.45% | 0.00% |
| Return on assets | (30.68%) | 5.40% | (6.05%) |
| Return on invested capital | (25.68%) | 6.76% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack